VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular...

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Mutations in the von Hippel-Lindau (VHL) gene are linked to VHL syndrome and sporadic renal cell cancer (RCC).
• Restoring VHL function in RCC cells can inhibit tumor growth in vivo but not in vitro.
• The role of extracellular matrix (ECM) signaling in VHL's tumor suppressor activity is not fully understood.

Purpose of the Study:

• To investigate the hypothesis that VHL tumor suppressor function depends on extracellular matrix (ECM) signaling.
• To elucidate the mechanisms by which VHL influences renal cell differentiation and growth.

Main Methods:

• Utilized 786-O VHL-deficient RCC cells and isogenic VHL-expressing sublines.
• Grew cells on various ECMs to assess VHL's response to cell-cell and cell-ECM interactions.
• Analyzed cell differentiation, proliferation, integrin levels, cell adhesion, and transcription factor expression (HNF1α).

Main Results:

• VHL-dependent differences in growth and differentiation were observed only when cells received cell-cell and cell-ECM signals.
• VHL-expressing cells differentiated into organized epithelial sheets, while VHL-deficient cells remained disorganized.
• VHL-expressing cells exhibited growth arrest at high density on collagen I, unlike VHL-deficient cells.
• Hepatocyte nuclear factor 1alpha (HNF1α) expression was significantly increased in VHL-expressing cells at high density.

Conclusions:

• VHL gene function requires integration of cell-cell and cell-ECM signaling for tumor suppression.
• VHL can promote renal cell differentiation and induce growth arrest.
• These findings highlight the importance of the tumor microenvironment in VHL's mechanism of action.